跳至主要内容
临床试验/NL-OMON41130
NL-OMON41130已完成不适用

Skin Fibroblasts for Cholesterol Research - Skin Fibroblasts for Cholesterol Research

Academisch Medisch Centrum0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patients with extreme tail LDL-C, HDL-C or TG levels, defined as >95% or <5% adjusted for sex and age, with a putative or proven molecular defect.
  • - Patients with premature atherosclerosis, defined as a first cardiovascular event <50 years for men and <55 years for women.
  • - Healthy family members as control
  • - Participating in Biobank Vascular Medicine (METC2014_082) and gave written consent for re-contact by the investigators for follow-up studies.

排除标准

  • Age <18 years

研究者

相似试验

已完成
4 期
Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSoundpatients aged 30-85 years who were undergoing percutaneous coronary intervention (PCI, elective or emergency) with &gt=1 significant stenosis &gt=75% and &gt=1 untouched nonculprit lesion of &lt=50% stenosis that could be imaged by intravascular ultrasound, and either LDL-C &gt=100 mg/dl.
JPRN-UMIN000002959Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University300
暂停
不适用
Cholesterol Metabolism in Plasma and Interstitial Fluid Among Subjects Undergoing Hemodialysis.Diabetic NephropathiesChronic Kidney DiseasesDiabetes Mellitus, Type 2
NCT03921216Karolinska University Hospital20
招募中
不适用
Serum levels of Cholesterol synthesis/absorption markers in subjects of various diseases.ormal subjects, Diabetes, Hyperlipidemia, Essential hypertension, Metabolic syndrome
JPRN-UMIN000004946Department of Metabolic Medicine, Faculty of life sciences, Kumamoto University600
已完成
不适用
Cholesterol Absorption and Cholesterol synthesis in High-risk patiEnts (CACHE study)1. Cardiovascular disease (coronary arterial disease, cerebrovascular disease, peripheral arterial disease) 2. Conditions at high risk of cardiovascular disease (diabetes mellitus, chronic kidney disease including stage 5D) 3. Those who do not have the above diseases
JPRN-UMIN000030635Osaka City University3,000
已完成
不适用
Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) StudyAtherosclerosis
NCT00258999University of Wisconsin, Madison600